investors.varian.comInvestor Information

-- -- Skip to main content Company Overview -- INVESTOR RELATIONS Stock price NYSE VAR Investor Menu Overview Press Releases Events & Presentations Financials and Filings Quarterly Results Annual Reports SEC Filings Stock Stock Quote and Chart Historical Price Lookup Stock Calculator Analyst Coverage Governance Management Board of Directors Committee Composition Guidelines Code of Conduct Management Stock Holdings Supplier Code of Conduct Resources Sign up for Email Alerts Investor Contacts Request for Printed Materials $3.2B FY 2019 REVENUES 10% REVENUES GROWTH IN FY 2019 9% ONCOLOGY ORDERS GROWTH IN FY 2019 5% NON-GAAP EPS 1 GROWTH IN FY 2019 $3.2B FY 2019 REVENUES 10% REVENUES GROWTH IN FY 2019 9% ONCOLOGY ORDERS GROWTH IN FY 2019 5% NON-GAAP EPS 1 GROWTH IN FY 2019 Press Releases Sign up for Email Alerts Feb 11, 2020 Varian Receives FDA 510(k) Clearance for Ethos Therapy Varian (NYSE: VAR) today announced it has received FDA 510(k) clearance for its Ethos™ therapy, an Adaptive Intelligence™ solution. Ethos therapy is an artificial intelligence (AI)-driven... Jan 29, 2020 Massachusetts General Hospital Selects Varian Radiotherapy Systems for Cancer Center Varian (NYSE: VAR) today announced it has signed an agreement with Massachusetts General Hospital to provide seven Varian radiotherapy systems and related services for advanced cancer treatment at... Jan 29, 2020 Varian Reports Results for First Quarter of Fiscal Year 2020 First Quarter 2020 Summary Oncology Systems gross orders grew 8% in dollars or 9% in constant currency in the quarter and over the trailing twelve months Total company revenues grew 12% in... Jan 20, 2020 Varian Appoints Prof. Dr. Ricky Sharma VP of Clinical Affairs Varian (NYSE: VAR) today announced it has appointed Dr. Ricky Sharma, to vice president of Clinical Affairs. In this role he will be leading medical research, translational science and clinical... View all press releases Upcoming Events No events to display View all events Past Events Annual Shareholders Meeting Thursday, February 13, 2020 4:30pm PST Participant Dial-In: 877-407-9708 / 201-689-8259 First Quarter FY2020 Earnings Results Conference Call Wednesday, January 29, 2020 1:30pm PST Teleconference: Access from within the U.S. by dialing 1-877-869-3847, and from outside the U.S. by dialing 1-201-689-8261. Replay: Access from within the U.S. by dialing 1-877-660-6853 and from... J.P. Morgan Healthcare Conference Monday, January 13, 2020 10:30am PST Webcast Q&A Webcast Varian Investor Day Friday, November 15, 2019 8:00am EST Registration is required. Please email Katie Glenn at katie.glenn@varian.com by November 8, 2019. View more events Quarterly Results Q1 FY20 Earnings Results Press Release Webcast Presentation 10-Q View all quarterly results Latest Annual Reports FY19 Annual Report FY18 Sustainability Report View all reports Contact Info Anshul Maheshwari VP, Treasurer and Investor Relations 1 650 424 6081 Anshul.Maheshwari@varian.com Contact information Varian Corporate Headquarters 3100 Hansen Way Palo Alto, CA 94304-1038 1 (650)424-5631 investors@varian.com Investor alerts Stay up to date on the latest investor information. Sign up...